Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management

Lauge Farnaes1, Julianne Wilke2, Kathleen Ryan Loker3

  • 1University of California San Diego, Department of Pediatrics, Division of Infectious Disease; Rady Children's Institute of Genomic Medicine.

Insights

Cell-free plasma next-generation sequencing (CFPNGS) significantly improves pathogen detection in pediatric community-acquired pneumonia (CAP). This advanced diagnostic method led to altered antibiotic management in nearly half of hospitalized children.

Area of Science:

  • Pediatric Infectious Diseases
  • Molecular Diagnostics
  • Genomic Medicine

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of pediatric hospitalizations.
  • Accurate and rapid pathogen identification is crucial for effective antibiotic therapy in severe CAP.
  • Antibiotic resistance poses a significant challenge in managing pediatric CAP.

Purpose of the Study:

  • To evaluate the impact of cell-free plasma next-generation sequencing (CFPNGS) on diagnosing pediatric CAP.
  • To compare the diagnostic yield of CFPNGS with standard-of-care methods.
  • To assess changes in antibiotic management resulting from CFPNGS use.

Main Methods:

  • Retrospective chart review of children hospitalized with CAP between June 2017 and January 2018.
  • Analysis of data from 15 pediatric patients who underwent CFPNGS.
  • Comparison of CFPNGS results with standard culture and PCR-based diagnostic techniques.

Main Results:

  • CFPNGS identified a pathogen in 86% (13/15) of pediatric CAP cases.
  • Standard methods alone detected pathogens in only 47% of cases.
  • Antibiotic management was adjusted in 47% (7/15) of children based on CFPNGS findings.

Conclusions:

  • CFPNGS offers a substantial improvement in pathogen detection for pediatric CAP compared to conventional methods.
  • This advanced sequencing technology can guide timely and appropriate antibiotic therapy adjustments.
  • CFPNGS represents a valuable tool for enhancing the diagnosis and management of severe pediatric CAP.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
807
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
What are Populations and Communities?00:30

What are Populations and Communities?

Overview
37.6K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
862
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.8K
Protein Buffers in Blood Plasma and Cells01:20

Protein Buffers in Blood Plasma and Cells

The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
3.8K